NCT02952508Phase 2Active not recruiting

Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom

Study sponsor: Cellectar Biosciences, Inc. · CLRB

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-06-22Estimated
Enrollment · participants120Estimated
Source updated2026-03-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 22 Dec 2025. After: 22 Jun 2026.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview